Oposura Capex mystery solved, page-37

Oh, that’s fine. My point was a general one. I agree much of the devil is in the detail with respect to the economics of the situation. Lots of uncertainties about there though and imo best to approach such developments with a full understanding of down-side risk

My previous post touched on a point I’d made previously about what mgmt may consider to be in the best interests of the company, and (even more fundamentally) what they consider ‘the company’ to be.

In some circumstances (eg subject to vested interest of mgmt in share price growth, and faced with challenges of raising capital multiples of market cap) interests of current shareholders and mgmt can cleave down fault lines that were previously obscured

Is Tony motivated solely by the desire to increase ROI for current shareholders? Or does he view the commmercialisation of Alacran as a crowning achievement of his career and an end in itself? Are these two objectives necessarily aligned in all instances. If not, and the latter were to take precedence, what ramifications may that have on capital raising outcomes?

None of this is specific to Azure or Tony. I have no real visibility of his motives or frame of mind. But the example of Heron shows how the interests of current shareholders can sometimes be trampled into the dirt when it serves the benefit of ‘the company’ to do so